News & Events
Bora Recognized with Dual Accolades at Asia Best Companies to Work for Awards 2024
《HR Asia》, the leading HR magazine in Asia, recently announced the winners of the 2024 “The HR Asia Best Companies to Work for in Asia Awards.” Bora Pharmaceuticals stood out among nearly 370 participating companies, not only winning the prestigious HR Asia Best Companies to Work for in Asia Taiwan 2024 award for the second time but also receiving the HR Asia Most Caring Company Awards 2024, recognizing its commitment to the “People First” philosophy since its inception as one of the core competences of the Bora Group.
Bio Asia-Taiwan 2024
We are attending Bio Asia-Taiwan 2024 in Taipei! Do you want to make success more certain? Connect with our team at the event!
Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility
Bora Pharmaceuticals announced it entered into an agreement for Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of a major commercial expansion for the Company.
Bora Wins Presidential Innovation Award, Award Prize Donation to Benefit Those Impacted by Earthquake
The Office of the President Taiwan announced the winners of the 6th “Presidential Innovation” Award, and Bora Pharmaceuticals has been awarded as the winner of the “President Innovation Award for Service Innovation”
Bio International 2024
We are attending Bio International 2024 in San Diego! Do you want to make success more certain? Connect with our team at the event!
Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
Bora Pharmaceuticals announced it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, USA.
SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient
SunWay Biotech and Gnosis by Lesaffre has announced a strategic partnership to launch their inaugural product, MenaQ7® Metabolic, featuring the ANKASCIN® 568-R.
Bio Korea 2024
We are attending Bio Korea 2024 in Seoul! Do you want to make success more certain? Connect with our team at the event!
Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion
Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer based in Minnesota, US, from shareholders, Sawai Group Holdings Co., Ltd. (JP), and Sumitomo Corporation of Americas, for a total consideration of up to US$210 million.